News & Views | Published:

A bone marrow factor contributes to kidney disease

Nature Medicine volume 23, pages 1314 (2017) | Download Citation

Soluble urokinase plasminogen activator receptor (suPAR) is a circulating biomarker of inflammation. A recent study identifies immature myeloid cells in the bone marrow as a major cellular source of suPAR that contributes to kidney disease.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    et al. Nat. Med. 14, 55–63 (2008).

  2. 2.

    et al. Nat. Med. 17, 952–960 (2011).

  3. 3.

    et al. Kidney Int. 87, 564–574 (2015).

  4. 4.

    et al. J. Intern. Med. 268, 296–308 (2010).

  5. 5.

    et al. N. Engl. J. Med. 373, 1916–1925 (2015).

  6. 6.

    Nat. Med. 23, 100–106 (2017).

Download references

Author information


  1. Stuart J. Shankland and J. Ashley Jefferson are in the Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington, USA.

    • Stuart J Shankland
    •  & J Ashley Jefferson


  1. Search for Stuart J Shankland in:

  2. Search for J Ashley Jefferson in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Stuart J Shankland.

About this article

Publication history



Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing